“Treatment or Psoriasis With Calcipotriene and Betamethasone Dipropionate (CAL BDP) Cream Showed Significantly Higher Proportion of Patients With an Absolute mPASI≤2 Compared to CAL BDP Gel Topical Suspension in a Post-Hoc Aanalysis of Two Phase 3 Studies”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s233, https://doi.org/10.25251/skin.7.supp.233.